Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
The super-enhancer, a cluster of enhancers with strong transcriptional activity, has become one of the most interesting topics in recent years. This study aimed to investigate pathogenic super-enhancer-driven genes in IBD and screen therapeutic drugs based on the results. In this study, through the...
Saved in:
Main Authors: | Hailong Li (Author), Jinhe Li (Author), Ting Xiao (Author), Yayue Hu (Author), Ying Yang (Author), Xiaoting Gu (Author), Ge Jin (Author), Hailong Cao (Author), Honggang Zhou (Author), Cheng Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling
by: Xiaoyang Wang, et al.
Published: (2022) -
Cebpb Regulates Skeletal Stem Cell Osteogenic Differentiation and Fracture Healing via the WNT/β-Catenin Pathway
by: Jiansong Wang, et al.
Published: (2022) -
IGF2 deficiency promotes liver aging through mitochondrial dysfunction and upregulated CEBPB signaling in d-galactose-induced aging mice
by: Xiaohai Zhou, et al.
Published: (2023) -
Nintedanib Inhibits Wnt3a-Induced Myofibroblast Activation by Suppressing the Src/β-Catenin Pathway
by: Xiaohe Li, et al.
Published: (2020) -
Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
by: Hailong Li, et al.
Published: (2021)